Literature DB >> 12095880

Randomised, controlled trial of the efficacy and safety of adapalene gel 0.1% and tretinoin cream 0.05% in patients with acne vulgaris.

William J Cunliffe1, F William Danby, Frank Dunlap, Michael H Gold, David Gratton, Alan Greenspan.   

Abstract

BACKGROUND: Previous clinical trials have shown that adapalene gel produces less irritation than tretinoin gels and tretinoin 0.025% cream. Short term results have shown that adapalene is less irritating than tretinoin gels and creams. This study is the first to compare the 0.1% formulation of adapalene gel with the 0.05% strength of tretinoin cream in a formal clinical trial.
OBJECTIVE: To investigate the efficacy and tolerability of adapalene gel 0.1% compared with tretinoin cream 0.05% in patients with mild-to-moderate acne vulgaris.
METHODS: Ten-week, multicentre, randomised, investigator-masked, active-controlled, parallel group study in 409 patients with acne vulgaris.
RESULTS: Adapalene gel 0.1% demonstrated equivalent efficacy in reduction of acne lesion counts and global improvement of acne severity over 10 weeks' treatment and was significantly better tolerated than tretinoin cream 0.05% in terms of erythema, dryness, desquamation and stinging/burning.
CONCLUSION: Adapalene gel 0.1% showed equivalent efficacy and was significantly better tolerated than tretinoin cream 0.05% in patients with mild-to-moderate acne vulgaris.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12095880

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  3 in total

Review 1.  Adapalene: a review of its use in the treatment of acne vulgaris.

Authors:  John Waugh; Stuart Noble; Lesley J Scott
Journal:  Drugs       Date:  2004       Impact factor: 9.546

2.  The efficacy of topical 0.1% adapalene gel for use in the treatment of childhood acanthosis nigricans: a pilot study.

Authors:  Arucha Treesirichod; Suthida Chaithirayanon; Nattakarn Wongjitrat; Pattra Wattanapan
Journal:  Indian J Dermatol       Date:  2015 Jan-Feb       Impact factor: 1.494

3.  Efficacy and tolerability of topical fixed combination of nadifloxacin 1% and adapalene 0.1% in the treatment of mild to moderate acne vulgaris in Indian patients: a multicenter, open-labelled, prospective study.

Authors:  Bela Jaswantlal Shah; Tharayil Kunneth Sumathy; Rachita Savalaram Dhurat; Raghunandan Govind Torsekar; Vishalakshi Viswanath; Jayesh Ishwardas Mukhi; Ganesh Kadhe; Pashmina Ahirrao
Journal:  Indian J Dermatol       Date:  2014-07       Impact factor: 1.494

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.